Reporting Vaccine Adverse Events
05 November 2021

Examples include the VAERS system (USA), EudraVigilance (EU) and the Yellow Card system (UK). As with severe disease and mortality associated with a recent positive SARS-COV-2 test, vaccine-associated events may result directly from the vaccine (the vaccine is causal) or reflect unrelated background disease that is not related to the vaccine. The voluntary or non-enforced nature of reporting also means that actual rates of reported events may represent only about 10% of the true rate.

These databases serve a vital function in identifying the occurrence of unusual events or higher than expected rates, spurring urgent investigation to ascertain the cause  and, in some circumstances, a halting of or withdrawal of the vaccine. This is critical as mass vaccination moves beyond controlled trials into populations who differ from the clinical trial population, or where rare but critical events are likely to have been missed in the smaller trial group. The rise in reports of adverse events in these three databases since the introduction of COVID-19 vaccines, which were introduced after relatively short trial periods, is an example of these systems working, and is intended to trigger urgent action to review safety and potential causality.

Click the flag to go to the reporting site.

United States
South Africa
United Kingdom
Europe
Canada
Germany
New Zealand
Austria
Austria
Switzerland
Switzerland
Australia
South Africa

Publisher’s note: The opinions and findings expressed in articles, reports and interviews on this website are not necessarily the opinions of PANDA, its directors or associates.

Share this

Post Tags

RELIABLE. RESEARCHED. RATIONAL.

YOU CAN SUPPORT PANDA’S WORK SO WE CAN REACH FURTHER

Our News In Your Inbox

Subscribe to our newsletter

RECENTLY ADDED TO THE SITE

Essential Questions to WHO on Pandemic Preparedness and Response

Essential Questions to WHO on Pandemic Preparedness and Response

In line with the founding principles of the WHO and orthodox principles of public health, PANDA has decided to publish its submission for the INB hearings in advance, to encourage open debate in ensuring global pandemic preparedness is underpinned by a strong evidence base, which gives full consideration to the COVID-19 response.